Serotransferrin delivers iron to all cells (Gkouvatsos et al., 2012) and has increased turnover in type 2 diabetes with enhanced systemic oxidative stress (Golizeh et al., 2017). This evidence concerns the gene TF and type 2 diabetes mellitus.